Automated Cell Counter Market Size - By Product Type (Fluorescence Image-based Cell Counter, Flow Cytometers, Coulter Counter), By Application (Blood Cells, Microbial Cells, Cell Lines), By End-use- Global Forecast, 2023

Description

List of Tables

Global Automated Cell Counter Market will witness over 5.5% CAGR between 2023 and 2032. The rising prevalence of chronic diseases and the need for accurate cell counting in medical diagnostics have spurred demand. For instance, as per the World Health Organization (WHO), Noncommunicable diseases (NCDs), commonly referred to as chronic ailments, result in the deaths of approximately 41 million individuals annually. This staggering figure represents 74% of all global fatalities.

Automated cell counters offer precise and efficient results, facilitating timely disease detection and monitoring. Advancements in biotechnology and pharmaceutical research necessitate high-throughput cell counting, propelling the adoption of automated systems. Additionally, the automation of laboratory processes improves workflow efficiency, reducing human error and increasing productivity. The increasing focus on personalized medicine and drug development requires precise cell counting, driving innovation and investment in the automated cell counter market outlook.

The overall Automated Cell Counter Market is classified based on product type, application, end-use, and region.

By product type, the coulter counter segment will witness 6% CAGR from 2023 to 2032. Coulter Counters, known for their accuracy in cell counting and sizing, have become essential tools in various fields, including healthcare, pharmaceuticals, and research. The demand for coulter counter products is driven by the need for rapid and precise cell analysis for research. As technology advances and automation becomes more prevalent, the coulter counter market is poised for sustained growth, meeting the evolving needs of industries reliant on cell analysis.

In terms of application, the cell lines segment will observe 5.4% CAGR from 2023 to 2032. Automated cell counters have become indispensable tools in biotechnology and pharmaceutical research, enabling rapid and accurate quantification of cell lines. This heightened demand stems from the escalating need for efficient cell culture monitoring, drug development, and vaccine production. As cell-based therapies and bioprocessing gain prominence, the automated cell counter market size from the cell lines segment is poised for robust growth.

By end-use, the hospitals segment will register 5.6% CAGR from 2023 to 2032. These sophisticated devices streamline the process of blood cell counting, aiding in the diagnosis and management of various medical conditions, including anemia, infections, and leukemia. With automation enhancing efficiency and accuracy, hospitals increasingly rely on these instruments to deliver timely and precise patient care. The automated cell counter market in hospitals is witnessing sustained growth due to the pivotal role of these devices in modern healthcare.

Regionally, the Europe automated cell counter market will showcase 4.2% CAGR from 2023 to 2032. European laboratories and medical facilities increasingly rely on automated cell counters to improve diagnostic accuracy and research efficiency. The growing prevalence of chronic diseases and the need for quicker and more accurate cell analysis are propelling the market. Moreover, stringent quality standards and regulatory compliance in Europe make automated cell counters indispensable tools for ensuring precision and reliability in various applications, further fueling industry growth.

Product Code: 5352

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market definitions
1.3 Base estimates and calculations
- 1.3.1 Data collection
1.4 Forecast calculations
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Automated cell counter industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Regional trends (USD Million & Units)
- 2.1.3 Product type trends (USD Million & Units)
- 2.1.4 Application trends
- 2.1.5 End-use trends

Chapter 3 Automated Cell Counter Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of chronic and infectious diseases
  - 3.2.1.2 Increasing R&D expenditure worldwide
  - 3.2.1.3 Technological advancements in automated cell counter industry
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of automated cell counter devices
  - 3.2.2.2 Lack of skilled workforce
3.3 Growth potential analysis
- 3.3.1 By product type
- 3.3.2 By application
- 3.3.3 By End-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Technological advancements in automated cell counter industry, 2022
3.7 Comparative analysis, 2022
- 3.7.1 Manual cell counter
- 3.7.2 Automated cell counter
3.8 Pricing analysis, 2022
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix

Chapter 5 Automated Cell Counter Market Size and Forecast, By Product Type (USD Million & Units)

5.1 Key trends, by product type
5.2 Fluorescence image-based cell counter
5.3 Flow cytometer
5.4 Coulter Counter

Chapter 6 Automated Cell Counter Market Size and Forecast, By Application (USD Million)

6.1 Key trends, by application
6.2 Blood cells
6.3 Cell lines
6.4 Microbial cells
6.5 Others

Chapter 7 Automated Cell Counter Market Size and Forecast, By End-use (USD Million)

7.1 Key trends, by end-use
7.2 Pharmaceutical & biotechnology companies
7.3 Hospitals
7.4 Diagnostic laboratories
7.5 Research institutes
7.6 Others

Chapter 8 Automated Cell Counter Market Size and Forecast, By Region (USD Million & Units)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 The Netherlands
- 8.3.7 Poland
- 8.3.8 Denmark
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Indonesia
- 8.4.7 Vietnam
- 8.4.8 Philippines
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Colombia
- 8.5.5 Chile
- 8.5.6 Peru
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Turkey

Chapter 9 Company Profiles

9.1 Abbott Laboratories
9.2 Bio-Rad Laboratories Inc
9.3 Thermo Fisher Scientific Inc
9.4 Danaher (Beckman Coulter Inc. and Radiometer)
9.5 Sysmex Corporation
9.6 NanoEnTek
9.7 F. Hoffmann-La Roche Ltd
9.8 Olympus Corporation
9.9 Agilent Technologies, Inc.
9.10 PerkinElmer, Inc.